window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

biomarkers

  • Clinical studies,Drug Development,Oncology,Precision medicine,Research & Development

    Nine-gene signature linked to lapatinib resistance in HER2-positive breast cancer

    Researchers at City St George’s, University of London have identified [...]

    January 29, 2026
  • Chronic diseases,Genomics and sequencing,Precision medicine,Research & Development

    Genomics and sequencing: Sapient study uses rLC-MS to map metabolic aging and disease insights in 26,000 samples

    Sapient has published a large-scale metabolomics study using its rapid [...]

    August 20, 2025
  • Clinical Development,Precision medicine,Rare Diseases,Real world evidence,Research & Development,Technology and platforms

    Nautilus and the Allen Institute partner to map tau proteoforms in Alzheimer’s disease research

    Nautilus Biotechnology has announced a new collaboration with the Allen [...]

    August 4, 2025
  • Clinical Development,Drug Development,Precision medicine,Rare Diseases,Technology and platforms

    Rewind Therapeutics strengthens Scientific Advisory Board with leading neurology experts as it advances remyelination therapy

    Appointments enhance clinical expertise as GPR17 modulator progresses toward trials [...]

    July 2, 2025
  • Clinical Trials

    Rein Therapeutics to integrate Qureight’s Deep-Learning Imaging Platform in Upcoming IPF Trial

    May 5, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ARTCLINE completes enrolment in septic shock trial for ARTICE therapy
    Categories: Biotech, Cell & Gene Therapy, Clinical Development, Clinical Trials, Infectious Diseases, Pharmaceuticals and therapeutics
  • SGD Pharma highlights GLP-1 demand, supply chain pressure and sustainability focus at DCAT Week
    Categories: CDMOs & Manufacturing, Healthcare leadership, Market Access & Commercialization, Pharmaceuticals and therapeutics, Supply Chain & Logistics
  • ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development
    Categories: Drug Delivery & Formulation, Drug Development, Oncology, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top